Harnessing reaction-based probes to preferentially target pancreatic β-cells and β-like cells

Sevim Kahraman1, Debasish Manna2,3,4, Ercument Dirice1

  • 1Islet Cell and Regenerative Biology, Joslin Diabetes Center, Department of Medicine, Brigham and Women's Hospital, Harvard Stem Cell Institute, Harvard Medical School, Boston, MA, USA.

Life Science Alliance
|January 30, 2021
PubMed